Remagine Labs to Present Data on Programmable Transdermal Delivery at AES 2025
Remagine Labs to Present at the 2025 American Epilepsy Society Annual Meeting in Atlanta
Austin, Texas – December 4, 2025 – Remagine Labs, a medical device company developing novel electro-pharmaceutical patches for epilepsy and other neurological disorders, today announced it will present data at the upcoming American Epilepsy Society (AES) Annual Meeting, taking place December 5–9, 2025, in Atlanta, Georgia.
The team will present a poster titled “A Programmable Transdermal Delivery System for Antiseizure Medication Delivery” (Poster 1.551) on Saturday, December 6, 2025, from 12:00 PM to 2:00 PM in Exhibit Hall B2.
The presentation will detail recent preclinical results for a wearable iontophoretic device designed to deliver antiseizure medications such as fenfluramine through the skin. The data demonstrates the system's ability to achieve significantly higher flux rates than passive patches, offering programmable dosing control and simulated plasma concentrations that support a move toward first-in-human trials.
“Epilepsy patients and their families face real challenges with current oral therapies, including side effects, drug–drug interactions, and adherence,” said Pat Kelly, Co-Founder and CEO of Remagine Labs. “Our goal with The Seizure Patch is to simplify treatment and improve precision by enabling electronic control of medication delivery through the skin. We are excited to share our latest validation data with the clinical community at AES.”
This development is a result of a strong collaboration between Remagine Labs and the University of Melbourne, alongside key partners AK Clinical Research and Monash University.
Remagine Labs gratefully acknowledges the support of the University of Melbourne Genesis Pre-Seed Fund, the Monash Ventures Pre-Seed Fund, Breakthrough Victoria, and the Australian Government’s CRC-P grant program, which are supporting the program’s progression toward clinical trials in 2026.
For more information on Remagine Labs and its upcoming presentation at AES 2025, please visit www.remaginelabs.com.
